… Non small cell lung cancer accounts for around 85% to 90% of deaths, whereas the rest is …
cell lung cancer. The extreme lethality of lung cancer arises due to lack of suitable diagnostic …

… cell lung cancer, it remains to be the leading cause of cancer-related deaths worldwide
primarily because of diagnosis at a … The diagnostic dilemma imposed by imaging modalities has …

An estimated 1.6 million new lung cancers are diagnosed … Five-year survival rates of lung
cancer patients have only … -cell lung cancer (SCLC) originates from neuroendocrine-cell …

… Cancer Registry (NCCR) of China in 2018–2015 showed that primary lung cancer was the
first cancer in … The diagnosis of early-stage non-small-cell lung cancer (NSCLC) was the first …

… from benign lung diseases is required. In conclusion, the use of tumour markers can be of
some help in the diagnosis of small-cell and non-small-cell lung cancer; cytokeratins in serum …

… To date, lung cancer is generally classified into two main categories: … cell lung cancer (NSCLC)
accounting for approximately 80 % of all lung cancers and small cell lung cancer (SCLC) …

… This section will focus on recent advances in systematic therapy of stage IV non–small
cell lung cancer because the greatest changes and advances have been made in this area. …

… as a potential marker for early diagnosis of NSCLC We further evaluated the potential of
using these biomarkers as diagnostic markers for early lung cancers by using a retrospective …

… with advanced-stage lung cancer (stage III and … diagnosis and staging of nonsmall cell lung
cancer, but surgery remains an important tool in the palliation of advanced-stage lung cancer…

… to the heterogeneous nature of cancer. In the case of lung cancer, although categorized in
small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) by histological character…